A review of the immunogenicity, safety and current recommendations for the meningococcal serogroup B vaccine, MenB‐FHbp
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A review of the immunogenicity, safety and current recommendations for the meningococcal serogroup B vaccine, MenB‐FHbp
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
Volume 45, Issue 2, Pages 270-281
Publisher
Wiley
Online
2019-12-10
DOI
10.1111/jcpt.13083
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Persistence and 4-year boosting of the bactericidal response elicited by two- and three-dose schedules of MenB-FHbp: A phase 3 extension study in adolescents
- (2019) Timo Vesikari et al. VACCINE
- National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2018
- (2019) Tanja Y. Walker et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Patterns of Primary Care Physician Visits for US Adolescents in 2014: Implications for Vaccination
- (2018) Cynthia M. Rand et al. Academic Pediatrics
- Knowledge and Attitudes Regarding Category B ACIP Recommendations Among Primary Care Providers for Children
- (2018) Allison Kempe et al. Academic Pediatrics
- Predicting the Susceptibility of Meningococcal Serogroup B Isolates to Bactericidal Antibodies Elicited by Bivalent rLP2086, a Novel Prophylactic Vaccine
- (2018) Lisa K. McNeil et al. mBio
- Evaluation of Mass Vaccination Clinics in Response to a Serogroup B Meningococcal Disease Outbreak at a Large, Public University—Oregon, 2015
- (2018) Emily A. Fisher et al. JOURNAL OF ADOLESCENT HEALTH
- Adoption of Serogroup B Meningococcal Vaccine Recommendations
- (2018) Allison Kempe et al. PEDIATRICS
- The bivalent factor H binding protein meningococcal serogroup B vaccine elicits bactericidal antibodies against representative non-serogroup B meningococci
- (2018) Shannon L. Harris et al. VACCINE
- Meningococcal Disease Among College-Aged Young Adults: 2014–2016
- (2018) Sarah A. Mbaeyi et al. PEDIATRICS
- Experience implementing a university-based mass immunization program in response to a meningococcal B outbreak
- (2018) Blair Capitano et al. Human Vaccines & Immunotherapeutics
- Meningococcal Carriage Following a Vaccination Campaign With MenB-4C and MenB-FHbp in Response to a University Serogroup B Meningococcal Disease Outbreak—Oregon, 2015–2016
- (2017) Lucy A McNamara et al. JOURNAL OF INFECTIOUS DISEASES
- Expanding state laws and a growing role for pharmacists in vaccination services
- (2017) Cason D. Schmit et al. JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION
- A Bivalent Meningococcal B Vaccine in Adolescents and Young Adults
- (2017) Lars Ostergaard et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Need to Optimize Adolescent Immunization
- (2017) Henry H. Bernstein et al. PEDIATRICS
- Effectiveness and Duration of Protection of One Dose of a Meningococcal Conjugate Vaccine
- (2017) Amanda C. Cohn et al. PEDIATRICS
- Understanding the Category B Recommendation for Serogroup B Meningococcal Vaccine
- (2017) Gary S. Marshall et al. PEDIATRICS
- Bactericidal activity of sera from adolescents vaccinated with bivalent rLP2086 against meningococcal serogroup B outbreak strains from France
- (2017) Muhamed-Kheir Taha et al. VACCINE
- Novel approaches to Neisseria meningitidis vaccine design
- (2017) Myron Christodoulides et al. Pathogens and Disease
- Serogroup B Meningococcus Outbreaks, Prevalence, and the Case for Standard Vaccination
- (2017) James Grogan et al. Current Infectious Disease Reports
- Updated Recommendations for Use of MenB-FHbp Serogroup B Meningococcal Vaccine — Advisory Committee on Immunization Practices, 2016
- (2017) Monica E. Patton et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Meningococcal Antigen Typing System (MATS)-Based Neisseria meningitidis Serogroup B Coverage Prediction for the MenB-4C Vaccine in the United States
- (2017) Gowrisankar Rajam et al. mSphere
- Serum Bactericidal Antibody Responses of Adults Immunized with the MenB-4C Vaccine against Genetically Diverse Serogroup B Meningococci
- (2016) Serena Giuntini et al. Clinical and Vaccine Immunology
- A Phase 2, Randomized, Active-controlled, Observer-blinded Study to Assess the Immunogenicity, Tolerability and Safety of Bivalent rLP2086, a Meningococcal Serogroup B Vaccine, Coadministered With Tetanus, Diphtheria and Acellular Pertussis Vaccine and Serogroup A, C, Y and W-135 Meningococcal Conjugate Vaccine in Healthy US Adolescents
- (2016) Derek Muse et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Immunogenicity, Tolerability and Safety in Adolescents of Bivalent rLP2086, a Meningococcal Serogroup B Vaccine, Coadministered with Quadrivalent Human Papilloma Virus Vaccine
- (2016) Shelly Senders et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Recommendations for Serogroup B Meningococcal Vaccine for Persons 10 Years and Older
- (2016) PEDIATRICS
- History of Meningococcal Outbreaks in the United States: Implications for Vaccination and Disease Prevention
- (2016) Bruce Atkinson et al. PHARMACOTHERAPY
- Characteristics of a new meningococcal serogroup B vaccine, bivalent rLP2086 (MenB-FHbp; Trumenba®)
- (2016) Ashesh Gandhi et al. POSTGRADUATE MEDICINE
- A phase 3, randomized, active-controlled study to assess the safety and tolerability of meningococcal serogroup B vaccine bivalent rLP2086 in healthy adolescents and young adults
- (2016) Lars Ostergaard et al. VACCINE
- Impact of pharmacists as immunizers on vaccination rates: A systematic review and meta-analysis
- (2016) J.E. Isenor et al. VACCINE
- Clinical experience with the meningococcal B vaccine, Bexsero ® : Prospects for reducing the burden of meningococcal serogroup B disease
- (2016) Philip S. Watson et al. VACCINE
- Immunogenicity, Safety, and Tolerability of Bivalent rLP2086 Meningococcal Group B Vaccine Administered Concomitantly With Diphtheria, Tetanus, and Acellular Pertussis and Inactivated Poliomyelitis Vaccines to Healthy Adolescents
- (2016) Timo Vesikari et al. Journal of the Pediatric Infectious Diseases Society
- Susceptibility of Meningococcal Strains Responsible for Two Serogroup B Outbreaks on U.S. University Campuses to Serum Bactericidal Activity Elicited by the MenB-4C Vaccine
- (2015) Raffaella Rossi et al. Clinical and Vaccine Immunology
- Five-year Antibody Persistence and Booster Response to a Single Dose of Meningococcal A, C, W and Y Tetanus Toxoid Conjugate Vaccine in Adolescents and Young Adults
- (2015) Roger Baxter et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Use of Serogroup B Meningococcal Vaccines in Adolescents and Young Adults: Recommendations of the Advisory Committee on Immunization Practices, 2015
- (2015) Jessica R. MacNeil et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Meningococcal Serogroup B Bivalent rLP2086 Vaccine Elicits Broad and Robust Serum Bactericidal Responses in Healthy Adolescents
- (2015) Timo Vesikari et al. Journal of the Pediatric Infectious Diseases Society
- Feasibility of a Pharmacy-Based Influenza Immunization Program in an Academic Emergency Department
- (2014) Victor Cohen et al. ANNALS OF PHARMACOTHERAPY
- Antibody Persistence and Booster Response of a Quadrivalent Meningococcal Conjugate Vaccine in Adolescents
- (2014) Roger Baxter et al. JOURNAL OF PEDIATRICS
- The Discovery and Development of a Novel Vaccine to Protect againstNeisseria meningitidisSerogroup B Disease
- (2014) Gary W Zlotnick et al. Human Vaccines & Immunotherapeutics
- Prevalence and genetic diversity of candidate vaccine antigens among invasive Neisseria meningitidis isolates in the United States
- (2011) Xin Wang et al. VACCINE
- A decade of experience with an inpatient pneumococcal vaccination program
- (2010) J. T. Robke et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Meningococcal carriage by age: a systematic review and meta-analysis
- (2010) Hannah Christensen et al. LANCET INFECTIOUS DISEASES
- Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal disease
- (2010) Han-Qing Jiang et al. VACCINE
- Bactericidal antibody is the immunologic surrogate of protection against meningococcal disease
- (2009) Carl E. Frasch et al. VACCINE
- Detection of LP2086 on the cell surface of Neisseria meningitidis and its accessibility in the presence of serogroup B capsular polysaccharide
- (2009) Lisa K. McNeil et al. VACCINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started